Atrial Fibrillation Surgery Market Revenue to Attain USD 16.95 Bn by 2035

Atrial Fibrillation Surgery Market Revenue and Trends 2026 to 2035

The global atrial fibrillation surgery market revenue reached USD 8.30 billion in 2025 and is predicted to attain around USD 16.95 billion by 2035 with a CAGR of 7.40%. The market is driven by the significant increase in the number of patients suffering from atrial fibrillation due to factors such as an aging population and lifestyle issues, and technological advancements in electrophysiology equipment.

Market Overview

The atrial fibrillation surgery market involves medical interventions that help achieve and sustain heart rhythm restoration for individuals suffering from atrial fibrillation. This market encompasses catheter ablation methods, which include radiofrequency and cryoablation. It also involves surgical procedures and hybrid procedures that address abnormal electrical conduction pathways within the heart.

The atrial fibrillation surgery in today’s era is done using advanced technologies such as mapping systems, ablation catheters, energy delivery systems, and image guidance systems, which allow the delivery of targeted treatment. This market also includes procedures conducted in cardiac care units and treatment centers where individuals have not responded to drug therapy.

What Drives the Atrial Fibrillation Surgery Market?

Technological Advancements

The market is benefitting from one of the most prominent recent innovations, that is, pulsed field ablation (PFA), a method that utilizes non-thermal energy to target cardiac tissues without causing any side effects to the esophagus and phrenic nerve. Latest medical treatments combine electroanatomical mapping and real-time lesion visualization with single-shot catheters that greatly accelerate the ablation procedure. These technologies also increase patient safety by minimizing risks associated with radiofrequency and cryoablation.

• In 2025, Medtronic’s Affera system, which is equipped with Sphere-360 and Sphere-9 catheters, showed promising results during its trials, indicating increased efficiency of pulmonary vein isolation.

Rapid Adoption of Left Atrial Appendage Closure Treatment

There is a rising adoption of left atrial appendage closure (LAAC) therapies as physicians seek to decrease stroke risk without resorting to chronic anticoagulation in patients at high risk of bleeding. LAAC is now more commonly employed as part of a full atrial fibrillation management strategy, especially within hospital-based cardiac departments, where it is used alongside rhythm-control therapies like catheter ablation.

• In 2025, Boston Scientific got permission from the FDA for broader use of its WATCHMAN FLX and FLX PRO platform, which can help promote LAAC use in combination with other treatments for stroke prevention in patients with atrial fibrillation.

Government Support for Better Accessibility of Atrial Fibrillation Treatment

Government policies are aimed at increasing access to atrial fibrillation ablation by ensuring safe and economical treatment due to modern reimbursement pathways. There is an increased adoption of outpatient and minimally invasive procedures for the treatment. Such steps increase access to medical facilities and promote quick intervention for those who have symptoms of atrial fibrillation.

• In 2025, CMS made a policy update that includes atrial fibrillation catheter ablation as one of the procedures covered by ASC reimbursement, thereby enabling patients to access the treatment through facilities other than those available at a hospital inpatient procedure.

Growing Global Prevalence of Atrial Fibrillation

The global prevalence of atrial fibrillation and atrial flutter rose significantly between 1990 and 2023, with the number of global prevalent cases around 58.99 million in 2023, 5.02 million incident cases, 376,862 fatalities, and 9.26 million disability-adjusted life years (DALYs). While the majority of cases are still amongst the older population, it was noted that a rise in cases was seen in younger and middle-aged patients.

Rising Global Burden of Atrial Fibrillation and Expanding Ablation Volumes are Reshaping Advanced Cardiac Rhythm Care

• European Heart Rhythm Association documents that the number of catheter ablations done per year in Europe is around 50000, with Germany, France, and the UK likely to have the largest number of electrophysiology centers in 2024-2026.
• Enhanced detection rates and the ageing of the population indicate that atrial fibrillation will impact over 11 million people in Europe by 2024-2025, with prevalence likely to increase substantially, according to the European Society of Cardiology.
• According to the data of the American Heart Association, more than 5 million individuals are living in the U.S. with atrial fibrillation as of 2024-2026.

Market Segmentation Overview

• By Surgery Type: The catheter ablation segment led the atrial fibrillation surgery market with a 55% share in 2025, as it is a minimally invasive procedure that offers better rhythm control than medication in addition to a faster healing period and increased success rate.
• By Surgery Type: The left atrial appendage closure (LAA) surgery segment is expected to expand at the highest CAGR of 8% during the forecast period, due to the fact that it is a great alternative for preventing strokes in atrial fibrillation patients who are unable to tolerate anticoagulant therapy.
• By Technology: The radiofrequency ablation (RFA) segment dominated the atrial fibrillation surgery market with a 50% share in 2025, owing to its widespread adoption, strong clinical history, and the ability to form lesions with a high procedure success rate.
• By Technology: The cryoablation segment held the second-largest market share of 25% in 2025 and is expected to grow at a significant CAGR of 7.5% between 2026 and 2035, as it is a safer and easier alternative to thermal ablation. It guarantees reliable separation of pulmonary veins without increasing the risk of complications such as pulmonary vein stenosis.
• By Procedure Type: The minimally invasive surgery segment led the atrial fibrillation surgery market with a 60% share in 2025, since it minimizes surgical complications, decreases hospitalization time, and is being rapidly adopted because of its high success rate.
• By Procedure Type: The traditional open surgery segment held the second-largest market share of 25% in 2025, as it continues to be used while dealing with advanced forms of atrial fibrillation, where correction of the heart requires both ablation and cardiac repair surgery.
• By End-Use: The hospitals segment dominated the atrial fibrillation surgery market with a 70% share in 2025. This is because these facilities deal with a significant volume of atrial fibrillation procedures, have superior electrophysiology setups, and are more suited to perform complex heart surgeries that require a team of experts in emergencies.
• By End-Use: The specialty cardiovascular clinics segment held the second-largest market share of 15% in 2025, owing to their specialized skills in electrophysiology treatment, efficient patient flow, and growing preference for less-invasive interventions that do not require hospitalization.
• By End-Use: The ambulatory surgical centers (ASCs) segment is expected to grow at the fastest rate from 2026 to 2035, since they provide low-cost procedures that can be done in less time and are being rapidly adopted to perform minimally invasive procedures for atrial fibrillation.

Regional Insights

North America led the atrial fibrillation surgery market with a 45% share in 2025, due to a significant prevalence of atrial fibrillation, significant presence of advanced ablation treatments, LAAC, and robust infrastructure for cardiac treatments. This region has favorable insurance coverage and early adoption of the latest technologies, which boosted the success rate of heart treatments. The U.S. led the market because of the presence of prominent players and significant investment from the government to drive innovation in the field of cardiology. Canada is a notable contributor to the market owing to the rapid adoption of electrophysiology and rising accessibility for minimally invasive cardiac treatments.

Asia Pacific is expected to expand at the highest rate from 2026 to 2035, due to rising incidences of heart issues, rapid improvement in healthcare facilities, and growing acceptance of minimally invasive procedures. This region is witnessing the rapid adoption of ablation and LAAC therapies. China led the market in Asia Pacific owing to its large population size, growing network of hospitals, and swift uptake of electrophysiology devices. India witnessed significant market growth because of improvements in cardiac treatment facilities and the rising availability of affordable minimally invasive therapies.

Atrial Fibrillation Surgery Market Coverage

Top Companies in the Atrial Fibrillation Surgery Market

Medtronic, Boston Scientific, Abbott Laboratories, and Johnson & Johnson (through its subsidiary Biosense Webster) are key players providing catheter-based equipment for cardiac ablation procedures. Biotronik and LivaNova offer cryoablation and surgical ablation systems used in the treatment of cardiac arrhythmias. In addition, Siemens Healthineers, GE HealthCare, and Philips Healthcare provide advanced imaging solutions such as intraoperative imaging and echocardiography that support procedural accuracy. Furthermore, Elekta and Stereotaxis specialize in robotic and magnetic navigation systems for catheter-based ablation procedures, enhancing precision and reducing procedural risk.

Segments Covered in the Report

By Surgery Type

• Catheter Ablation (RF Ablation, Cryoablation)
• Maze Surgery
• Left Atrial Appendage Closure (LAA) Surgery
• Hybrid Procedures
• Others

By Technology

• Radiofrequency Ablation (RFA)
• Cryoablation
• Laser Ablation
• Microwave Ablation
• Electroporation & Others

By Procedure Type

• Minimally Invasive Surgery
• Traditional Open Surgery
• Hybrid Surgery

By End-Use

• Hospitals
• Specialty Cardiovascular Clinics
• Ambulatory Surgical Centers (ASCs)
• Research Institutions

By Region

• North America
• Latin America
• Europe
• Asia-pacific
• Middle and East Africa

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/8334

You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344